In-vitro evaluation of antimicrobial activity of Dhupana drugs on Staphylococcus aureus
Keywords:Multidrug resistance, dhupana karma, antimicrobial agents
Multidrug resistance in the notorious bacterial strains is accounting for a tremendous increase in global mortality rate. The upcoming new generation antibiotics are granting a perceptive provision in this issue but the superbugs have enforced these antimicrobial agents to surrender by developing the innovative variation in their genes/ plasmids. So alternatives are desired to combat this problem. Herbal drugs may broaden this spectrum of antimicrobial agents by offering safer and promising approach. Dhupana karma is such a modality known for its antimicrobial activity due to its indication in infectious diseases as per classical texts. The present study included fumigation on Staphyloccus aureus with four Dhupana formulations to assess their antimicrobial activity. The assessment criteria taken was mean bacterial colony count after 20 min of fumigation compared with control (without fumigation). Statistical analysis was done using Anova test and Tukey Kramer comparison test. The % change in mean colony count of B1 (S.aureus) after 20 min of fumigation was found to be 76.61 % with drug D1 (Nimbadi Dhupa), 84.13 % with drug D2 (Kumaragara Dhupa), 80.51 % with drug D3 (Dashanga Dhupa) and 98.94 % with drug D4 (Gana Dhupa).
How to Cite
Copyright (c) 2019 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.